Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models
经过改造的肉毒杆菌毒素 B 与人类受体的结合能力得到改善，在临床前模型中提高了疗效
期刊:Science Advances
影响因子:11.7
doi:10.1126/sciadv.aau7196
Mark Elliott, Christine Favre-Guilmard, Sai Man Liu, Jacquie Maignel, Geoffrey Masuyer, Matthew Beard, Christopher Boone, Denis Carré, Mikhail Kalinichev, Stephane Lezmi, Imran Mir, Camille Nicoleau, Shilpa Palan, Cindy Perier, Elsa Raban, Sicai Zhang, Min Dong, Pål Stenmark, Johannes Krupp
